HOME >> BIOLOGY >> NEWS
Promising preclinical results with live attenuated H5N1 vaccines

Several approaches are in progress to develop vaccines against the avian flu variety of the influenza virus. Kanta Subbarao (National Institutes of Health) and colleagues are working on live attenuated vaccines, which have the potential to elicit a strong, broad, and lasting immune response. As they now report in the international open-access medical journal PLoS Medicine, results from mice and ferrets (the rodent flu model of choice) are very encouraging and pave the way to testing these vaccines in human volunteers.

The researchers developed vaccines using 3 artificially constructed, weakened forms of the influenza virus. The 3 vaccine viruses were constructed using flu virus proteins other than H and N from artificially weakened (attenuated) strains of influenza. These were combined with H and N proteins from H5N1 viruses isolated from human cases during three different years: 2004, 2003, and 1997. They grew larger quantities of the resulting viruses in hen eggs, and tested the vaccines in chickens, ferrets, and mice.

In tests of safety, the study found that, unlike the natural viruses from which they were derived, the vaccine strains did not cause death when injected into the bloodstream of chickens, and did not even cause persistent infection when given through the birds' breathing passages. Similarly, while the natural viruses were lethal in mice at various doses, the vaccine strains did not cause death even at the highest dose. In ferrets, infection with the vaccine strains was limited to the upper respiratory tract, while the natural viruses spread eadily to the lungs.

In tests of protection, all mice that had received any of the 3 vaccines survived following injection with any of the natural viruses (so-called viral challenge), while unvaccinated mice died following viral challenge. This occurred even though standard blood tests could not detect a strong immune responses following a single dose of vaccine. Challenge virus was
'"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
11-Sep-2006


Page: 1 2

Related biology news :

1. Promising protein may prevent eye damage in premature babies
2. Tailored treatments: Promising designer drug provides new insight into cancer biology
3. Promising antiobesity drug fails to produce clinically meaningful weight loss
4. Promising new research on hereditary diseases
5. Promising cell protein may play role in infection and dry eye
6. Promising anti-TB compound finally can be synthesized with ease
7. Promising results in the battle against incurable ALS muscle disease
8. Promising new preventative treatment option for population of men at high risk of prostate cancer
9. Serica scientists win AOSSM Award for ACL (knee) tissue regeneration in preclinical study
10. Fatty spheres loaded with siRNA shrink ovarian cancer tumors in preclinical trial
11. Tramiprosate (Alzhemed) preclinical results published in Neurobiology of Aging

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2020)... ... May 26, 2020 , ... ... announced that Gritstone Oncology, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, ... TCR-based therapeutics, has implemented Genedata Biologics ® within their R&D organization. ...
(Date:5/21/2020)... CARY, N.C. (PRWEB) , ... ... ... Solutions , the leading software-as-a-service (SaaS) provider of operations management solutions, today ... new BioMed module provides a cloud-based platform for connecting the people and ...
(Date:5/21/2020)... Mass. (PRWEB) , ... May 21, 2020 , ... ... orthopedic care across the North Shore and Greater Boston area, is pleased to ... , As one of the busiest group practices in the area, Agility Orthopedics ...
Breaking Biology News(10 mins):
(Date:5/14/2020)... ... May 13, 2020 , ... ... phenotypic readouts, providing little or no information on the drug’s mechanism of action ... characterization of compounds by measuring the activity of molecular pathways. This information can ...
(Date:5/5/2020)... , ... May 05, 2020 , ... ProductLife Group ... high-profile CEO. Xavier Duburcq joins the group after 13 years at Altran, where he ... Holding a PhD in Immunology and being a Pharmacist, Xavier was involved in his ...
(Date:4/26/2020)... NEW YORK (PRWEB) , ... April 23, 2020 ... ... in the Azure Marketplace today, an online store providing applications and services for ... organizations with certain well-defined business needs to sign up online for a built-for-purpose ...
(Date:4/22/2020)... ... April 21, 2020 , ... Aniara Diagnostica ... of FXIII. , Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, ... standards for product quality and cost-efficient delivery. , For Research Use ...
Breaking Biology Technology:
Cached News: